In vivo mouse models to study bile acid synthesis and signaling.


Journal

Hepatobiliary & pancreatic diseases international : HBPD INT
ISSN: 1499-3872
Titre abrégé: Hepatobiliary Pancreat Dis Int
Pays: Singapore
ID NLM: 101151457

Informations de publication

Date de publication:
Oct 2023
Historique:
received: 12 06 2023
accepted: 09 08 2023
medline: 3 10 2023
pubmed: 25 8 2023
entrez: 24 8 2023
Statut: ppublish

Résumé

The synthesis of bile acids (BAs) is carried out by complex pathways characterized by sequential chemical reactions in the liver through various cytochromes P450 (CYP) and other enzymes. Maintaining the integrity of these pathways is crucial for normal physiological function in mammals, encompassing hepatic and neurological processes. Studying on the deficiencies in BA synthesis genes offers valuable insights into the significance of BAs in modulating farnesoid X receptor (FXR) signaling and metabolic homeostasis. By creating mouse knockout (KO) models, researchers can manipulate deficiencies in genes involved in BA synthesis, which can be used to study human diseases with BA dysregulation. These KO mouse models allow for a more profound understanding of the functions and regulations of genes responsible for BA synthesis. Furthermore, KO mouse models shed light on the distinct characteristics of individual BA and their roles in nuclear receptor signaling. Notably, alterations of BA synthesis genes in mouse models have distinct differences when compared to human diseases caused by the same BA synthesis gene deficiencies. This review summarizes several mouse KO models used to study BA synthesis and related human diseases, including mice deficient in Cyp7a1, Cyp27a1, Cyp7a1/Cyp27a1, Cyp8b1, Cyp7b1, Cyp2c70, Cyp2a12, and Cyp2c70/Cyp2a12, as well as germ-free mice.

Identifiants

pubmed: 37620226
pii: S1499-3872(23)00128-5
doi: 10.1016/j.hbpd.2023.08.009
pii:
doi:

Substances chimiques

Bile Acids and Salts 0
Receptors, Cytoplasmic and Nuclear 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

466-473

Subventions

Organisme : NIEHS NIH HHS
ID : R25 ES020721
Pays : United States
Organisme : NIEHS NIH HHS
ID : T32 ES007148
Pays : United States

Informations de copyright

Copyright © 2023 First Affiliated Hospital, Zhejiang University School of Medicine in China. Published by Elsevier B.V. All rights reserved.

Auteurs

Anisha Bhattacharya (A)

Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, New Jersey, USA.

Rulaiha E Taylor (RE)

Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, New Jersey, USA; Rutgers Center for Lipid Research, Rutgers, The State University of New Jersey, New Brunswick, New Jersey, USA.

Grace L Guo (GL)

Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, New Jersey, USA; Rutgers Center for Lipid Research, Rutgers, The State University of New Jersey, New Brunswick, New Jersey, USA; Environmental and Occupational Health Sciences Institute, Rutgers, The State University of New Jersey, Piscataway, New Jersey, USA; VA New Jersey Health Care System, Veterans Administration Medical Center, East Orange, New Jersey, USA. Electronic address: guo@eohsi.rutgers.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH